{"organizations": [], "uuid": "786bde6f92f7bc583c6b08f0529932d4b2814f05", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180122.html", "section_title": "Archive News &amp; Video for Monday, 22 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sms-pharmaceuticals-gets-eir-from/brief-sms-pharmaceuticals-gets-eir-from-u-s-fda-for-manufacturing-facility-in-hyderabad-idUSFWN1PH074", "country": "US", "domain_rank": 408, "title": "BRIEF-SMS Pharmaceuticals Gets EIR From U.S. FDA for Manufacturing Facility in Hyderabad", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.655, "site_type": "news", "published": "2018-01-22T17:05:00.000+02:00", "replies_count": 0, "uuid": "786bde6f92f7bc583c6b08f0529932d4b2814f05"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sms-pharmaceuticals-gets-eir-from/brief-sms-pharmaceuticals-gets-eir-from-u-s-fda-for-manufacturing-facility-in-hyderabad-idUSFWN1PH074", "ord_in_thread": 0, "title": "BRIEF-SMS Pharmaceuticals Gets EIR From U.S. FDA for Manufacturing Facility in Hyderabad", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "hyderabad", "sentiment": "none"}, {"name": "us", "sentiment": "none"}, {"name": "hyderabad", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "sms pharmaceuticals ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - Sms Pharmaceuticals Ltd:\n* GETS ESTABLISHMENT INSPECTION REPORT(EIR) FROM US FDA * SAYS THERE WERE NO FORM 483 OBSERVATIONS DURING OF FACILITY IN HYDERABAD Source text - bit.ly/2BjYi32 Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2BjYi32"], "published": "2018-01-22T17:05:00.000+02:00", "crawled": "2018-01-23T17:50:03.005+02:00", "highlightTitle": ""}